Absence of somatic mutations within the Runt domain of AML2/RUNX3 in acute myeloid leukaemia
Open Access
- 29 July 2003
- journal article
- other
- Published by Springer Nature in Leukemia
- Vol. 17 (8) , 1677-1678
- https://doi.org/10.1038/sj.leu.2403007
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Heterozygous PU.1 mutations are associated with acute myeloid leukemiaBlood, 2002
- Unlike AML1, CBFβ gene is not deregulated by point mutations in acute myeloid leukemia and in myelodysplastic syndromesBlood, 2002
- Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-α (C/EBPα), in acute myeloid leukemiaNature Genetics, 2001
- Mutations of the AML1 gene in myelodysplastic syndrome and their functional implications in leukemogenesisBlood, 2000
- High incidence of biallelic point mutations in the Runt domain of the AML1/PEBP2αB gene in Mo acute myeloid leukemia and in myeloid malignancies with acquired trisomy 21Blood, 2000
- Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemiaNature Genetics, 1999
- Regulation of AML2/CBFA3 in Hematopoietic Cells through the Retinoic Acid Receptor α-Dependent Signaling PathwayJournal of Biological Chemistry, 1999
- Biallelic and Heterozygous Point Mutations in the Runt Domain of theAML1/PEBP2B Gene Associated With Myeloblastic LeukemiasBlood, 1999